$CNC

2 Non-AI Giants to Buy on Solid Guidance and Lucrative Valuation

Centene Corp. (CNC) and Archer-Daniels-Midland Co. (ADM) are highlighted for strong performance and attractive valuations. CNC expects 2026 revenues of $173-$177B and adjusted EPS over $4.80, with a forward P/E of 13.58X. ADM raised 2026 adjusted earnings guidance to $5.15-$5.60 per share, with a forward P/E of 16.60X.

Original reporting
Published Sep 15, 2026, 12:06 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 4:00 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
2 Non-AI Giants to Buy on Solid Guidance and Lucrative Valuation — source image
Decision brief

The 30-second read

$CNCBullishMed
01

Why it matters

New guidance lifts earnings expectations, which could drive price appreciation, but investors should monitor policy and commodity risks.

02

Market read

Guidance upgrades for CNC and ADM provide fresh material for traders seeking upside in healthcare and agribusiness sectors.

03

What to watch

Potential headwinds from Medicaid policy changes and commodity price volatility could temper gains.

Relevance 7/10Novelty 7/10Timing: guidance update released today

Background

The article highlights two non‑AI stocks with strong Zacks Rank #1 and updated 2026 guidance, positioning them as attractive buys for the remainder of the year.

Company-level read

Ticker impact

$CNCBullishHigh confidence
Context

Centene Corp. raised its 2026 revenue guidance to $173‑$177 B and adjusted EPS to >$4.80, a fresh update disclosed in this article.

Expected impact

Potential upside of 5‑10% over the next weeks if market digests the guidance.

Evidence & confidence

Guidance beats prior expectations and EPS outlook improves >130%, indicating strong upside.

$ADMBullishHigh confidence
Context

Archer‑Daniels‑Midland announced 2026 adjusted earnings guidance of $5.15‑$5.60 per share, up from $4.15‑$4.70, a new disclosure.

Expected impact

Expect modest rally of 3‑7% as investors price in higher earnings.

Evidence & confidence

Guidance increase reflects better margins from renewable fuel obligations and higher energy prices.

Market effects

Both healthcare and agribusiness sectors may see uplift as peers' guidance improves.

U.S. markets could see modest gains in related ETFs tracking health services and commodities.

Positive guidance may reinforce confidence in AI‑linked growth themes globally.

Counterpoint

If guidance improvements are already priced in, the stocks may face limited upside.

Key entities

  • Centene Corp.

    U.S. healthcare services provider

  • Archer‑Daniels‑Midland Co.

    U.S. agribusiness and food processing company

Related articles

$CNCMed

CNC Looks 14.6% Undervalued on GF Value™ as Market Prices in Gro

Centene Corporation (CNC) reaffirmed its 2026 adjusted diluted EPS forecast, expecting it to exceed $4.80, slightly below analyst consensus. The company's P/S ratio is 0.16, below its historical median and industry average, reflecting market skepticism. Its GF Score™ is 72/100, indicating moderate financial health. Insider activity shows no buying and $14.6 million in selling, while institutional sentiment is mixed.

$ADMMedAI 8/10

SEC Produces 307,000 Documents in Fraud Case Against Former ADM CFO

The SEC has produced 307,000 documents in its fraud case against former ADM CFO Vikram Luthar, with ongoing document production. The case involves alleged inflation of ADM's Nutrition business performance. ADM settled related charges with a $40M penalty. Discovery is expected to continue until March 2027. Luthar is contesting the allegations in court.

$ADMMedAI 8/10

Archer Daniels Targets $500M-$750M in Savings: Can It Deliver?

Archer Daniels Midland (ADM) aims to achieve $500M-$750M in cost savings over 3-5 years through efficiency improvements. The company has already realized $200M in savings in 2025 and reported a 75% year-over-year increase in segment operating profit to $1.5B in Q2 2026. ADM's shares have gained 26.2% in the past six months, trading at a forward P/E of 15.6X. Analysts expect EPS growth of 52.2% and 3.5% for 2026 and 2027, respectively.

$CNCMed

CNC, OSCR Stocks Rally After Baird Calls Risk Adjustment Results Favorable

Centene (CNC) and Oscar Health (OSCR) shares rose 6% and 12% respectively after Baird reported favorable risk adjustment results. Baird noted the outcomes support Centene's Q4 commentary and align with Oscar's June investor conference remarks. Molina (MOH) shares also rose 2% despite a minor negative impact. The Centers for Medicare & Medicaid Services released final 2025 risk adjustment data on June 30, affecting insurers' earnings.

$ADMMed

Can Flavors Keep Driving Archer Daniels' Human Nutrition Growth?

Archer Daniels Midland (ADM) reports strong growth in its Flavors business, a key driver of its Human Nutrition segment. Q2 2026 operating profit rose 51% YoY to $139M, with Flavors sales increasing globally. ADM expects mid-single-digit growth for Flavors, citing strong demand for natural and healthier products, particularly in Asia Pacific. The company's investments and acquisitions have bolstered its Flavors capabilities.

$CNCMed

Centene (CNC) Hands Its Turnaround Playbook To A New Tech Chief

Centene Corporation (CNC) appointed Bradley Bolivar as its new Chief Information Officer, replacing Brian LeClaire. Bolivar brings extensive tech leadership experience, including roles at Fannie Mae and Warner Bros. Centene reported Q2 earnings of $2.19 GAAP EPS and $2.51 adjusted EPS, raising its full-year adjusted EPS guidance above $4.80. The company's health benefits ratio improved, but total at-risk membership declined. Centene trades at a forward P/E ratio of 13.12 as of September 1.